Literature DB >> 11994037

Formulations of antibiotics for children in primary care: effects on compliance and efficacy.

Andres Ramgoolam1, Russell Steele.   

Abstract

This review article is designed for pediatricians as well as primary care physicians in the outpatient setting as a clinical guide to antibiotic selection. It emphasizes variables related to compliance as well as efficacy. The aim is to give recommendations as to the choice of antibiotics, depending on factors such as taste, cost, efficacy, and compliance. Common bacterial pathogens causing infections in children are reviewed, along with their susceptibility patterns to antimicrobial agents. Emerging mechanisms of resistance, particularly the increasing resistance of pneumococci to beta-lactam antibiotics, are discussed because of their importance to antibiotic selection. Previously published studies that have examined the treatment of common outpatient infections in children, such as otitis media, streptococcal tonsillopharyngitis, and sinusitis, are summarized. Adverse reactions associated with antibiotics, second in importance only to efficacy, are reviewed. Finally, compliance issues, which include palatability, cost, duration of therapy, and administration frequency, are analyzed using recently published information related to each of these issues. The efficacy of the commonly used antibiotics for urinary tract infections, pneumonia, and streptococcal pharyngitis does not vary significantly; however, for otitis media and sinusitis, some studies have shown that treatment efficacy with the antibiotic does not vary significantly from that with placebo. Likewise, adverse reactions rarely provide a basis for antibiotic selection, since virtually all antibiotics are generally well tolerated. The final factor, compliance, is a major issue in determining both first- and second-line therapy of common outpatient infections in children. Although cost is not a factor in compliance in countries such as the UK where no copayment is required for pediatric drugs, it is of major importance in the US. This is followed by palatability, administration duration and finally administration frequency. As a group, cephalosporins are generally the best tasting but are relatively more expensive than macrolides. Antibiotics that can be given for 5 days, and just once or twice daily, are preferred by most parents and physicians. Since final assessment of antibiotic choice is likely to vary considerably among healthcare personnel, decisions must be made on an individual basis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11994037     DOI: 10.2165/00128072-200204050-00005

Source DB:  PubMed          Journal:  Paediatr Drugs        ISSN: 1174-5878            Impact factor:   3.022


  65 in total

Review 1.  A practical guide for the diagnosis and treatment of acute sinusitis.

Authors:  D E Low; M Desrosiers; J McSherry; G Garber; J W Williams; H Remy; R S Fenton; V Forte; M Balter; C Rotstein; C Craft; J Dubois; G Harding; M Schloss; M Miller; R A McIvor; R J Davidson
Journal:  CMAJ       Date:  1997-03-15       Impact factor: 8.262

2.  Prevalence of antimicrobial resistance among respiratory tract isolates of Streptococcus pneumoniae in North America: 1997 results from the SENTRY antimicrobial surveillance program.

Authors:  G V Doern; M A Pfaller; K Kugler; J Freeman; R N Jones
Journal:  Clin Infect Dis       Date:  1998-10       Impact factor: 9.079

3.  Community-acquired methicillin-resistant Staphylococcus aureus in children with no identified predisposing risk.

Authors:  B C Herold; L C Immergluck; M C Maranan; D S Lauderdale; R E Gaskin; S Boyle-Vavra; C D Leitch; R S Daum
Journal:  JAMA       Date:  1998-02-25       Impact factor: 56.272

4.  Antibiotic susceptibility of multiply resistant Pseudomonas aeruginosa isolated from patients with cystic fibrosis, including candidates for transplantation.

Authors:  L Saiman; F Mehar; W W Niu; H C Neu; K J Shaw; G Miller; A Prince
Journal:  Clin Infect Dis       Date:  1996-09       Impact factor: 9.079

Review 5.  The role of newer oral cephalosporins, fluoroquinolones, and macrolides in the treatment of pediatric infections.

Authors:  W J Rodriguez; B L Wiedermann
Journal:  Adv Pediatr Infect Dis       Date:  1994

Review 6.  Pharmacodynamics and pharmacokinetics of cefdinir, an oral extended spectrum cephalosporin.

Authors:  D R Guay
Journal:  Pediatr Infect Dis J       Date:  2000-12       Impact factor: 2.129

Review 7.  Clindamycin, metronidazole, and chloramphenicol.

Authors:  M J Kasten
Journal:  Mayo Clin Proc       Date:  1999-08       Impact factor: 7.616

8.  Azithromycin compared with cephalexin in the treatment of skin and skin structure infections.

Authors:  S B Mallory
Journal:  Am J Med       Date:  1991-09-12       Impact factor: 4.965

Review 9.  Management of infections caused by antibiotic-resistant Streptococcus pneumoniae.

Authors:  I R Friedland; G H McCracken
Journal:  N Engl J Med       Date:  1994-08-11       Impact factor: 91.245

10.  In vitro and in vivo evaluation of A-56268 (TE-031), a new macrolide.

Authors:  P B Fernandes; R Bailer; R Swanson; C W Hanson; E McDonald; N Ramer; D Hardy; N Shipkowitz; R R Bower; E Gade
Journal:  Antimicrob Agents Chemother       Date:  1986-12       Impact factor: 5.191

View more
  9 in total

Review 1.  Role of beta-lactam agents in the treatment of community-acquired pneumonia.

Authors:  J Garau
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2005-02       Impact factor: 3.267

2.  Parent-reported outcomes for treatment of acute otitis media with cefdinir or amoxicillin/clavulanate oral suspensions.

Authors:  Mary A Cifaldi; Maria M Paris; Karen J Devcich; Stanley Bukofzer
Journal:  Paediatr Drugs       Date:  2004       Impact factor: 3.022

3.  Study of the acceptability of antibiotic syrups, suspensions, and oral solutions prescribed to pediatric outpatients.

Authors:  Robert Cohen; France de La Rocque; Aurélie Lécuyer; Claudie Wollner; Marie Josée Bodin; Alain Wollner
Journal:  Eur J Pediatr       Date:  2008-10-29       Impact factor: 3.183

4.  The management of community-acquired pneumonia in infants and children older than 3 months of age: clinical practice guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America.

Authors:  John S Bradley; Carrie L Byington; Samir S Shah; Brian Alverson; Edward R Carter; Christopher Harrison; Sheldon L Kaplan; Sharon E Mace; George H McCracken; Matthew R Moore; Shawn D St Peter; Jana A Stockwell; Jack T Swanson
Journal:  Clin Infect Dis       Date:  2011-08-31       Impact factor: 9.079

5.  Modification of bitter taste in children.

Authors:  Julie A Mennella; M Yanina Pepino; Gary K Beauchamp
Journal:  Dev Psychobiol       Date:  2003-09       Impact factor: 3.038

Review 6.  Current issues in pediatric medication adherence.

Authors:  Doreen Matsui
Journal:  Paediatr Drugs       Date:  2007       Impact factor: 3.022

Review 7.  Cefdinir: a review of its use in the management of mild-to-moderate bacterial infections.

Authors:  Caroline M Perry; Lesley J Scott
Journal:  Drugs       Date:  2004       Impact factor: 9.546

8.  Are children carrying the burden of broad-spectrum antibiotics in general practice? Prescription pattern for paediatric outpatients with respiratory tract infections in Norway.

Authors:  Guro Haugen Fossum; Morten Lindbæk; Svein Gjelstad; Ingvild Dalen; Kari J Kværner
Journal:  BMJ Open       Date:  2013-01-07       Impact factor: 2.692

9.  Characterisation of antibiotic prescriptions for acute respiratory tract infections in Danish general practice: a retrospective registry based cohort study.

Authors:  Rune Aabenhus; Malene Plejdrup Hansen; Laura Trolle Saust; Lars Bjerrum
Journal:  NPJ Prim Care Respir Med       Date:  2017-05-19       Impact factor: 2.871

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.